XTRA:BAYNPharmaceuticals
Bayer Litigation Deal And Cancer Data Reframe Risk Reward For Investors
Bayer received preliminary court approval for a multibillion euro Roundup class action settlement, addressing a large portion of ongoing litigation.
The company reported positive late stage clinical data in prostate cancer, including survival benefits for radium 223 (XOFIGO) in combination therapy and first in human data for a next generation targeted alpha therapy.
The FDA cleared expanded capabilities for Bayer's MEDRAD MRXperion MR injection system in the United States.
Bayer entered an...